41422-2025 - Result
Spain – Various medicinal products – El objeto del contrato viene determinado por el suministro del principio activo denominado "ANIFROLUMAB 300MG/2MLVIAL PERFUSION".
OJ S 14/2025 21/01/2025
Contract or concession award notice – standard regime
Supplies
1. Buyer
1.1.
Buyer
Official name: Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Email: ucahugcdn.scs@gobiernodecanarias.org
Legal type of the buyer: Regional authority
Activity of the contracting authority: General public services
2. Procedure
2.1.
Procedure
Title: El objeto del contrato viene determinado por el suministro del principio activo denominado "ANIFROLUMAB 300MG/2MLVIAL PERFUSION".
Description: El objeto del contrato viene determinado por el suministro del principio activo denominado "ANIFROLUMAB 300MG/2MLVIAL PERFUSION".
Procedure identifier: 85db57b0-03ea-499d-8e6c-338552226b65
Internal identifier: SUM/2024/0000032703
Type of procedure: Negotiated without prior call for competition
2.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33690000 Various medicinal products
2.1.2.
Place of performance
Country subdivision (NUTS): Gran Canaria (ES705)
Country: Spain
2.1.4.
General information
Legal basis: 
Directive 2014/24/EU
5. Lot
5.1.
Lot: LOT-0000
Title: El objeto del contrato viene determinado por el suministro del principio activo denominado "ANIFROLUMAB 300MG/2MLVIAL PERFUSION".
Description: El objeto del contrato viene determinado por el suministro del principio activo denominado "ANIFROLUMAB 300MG/2MLVIAL PERFUSION".
Internal identifier: SUM/2024/0000032703
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33690000 Various medicinal products
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.7.
Strategic procurement
Aim of strategic procurement: No strategic procurement
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: PRECIO.
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín - Tribunal Administrativo de Contratos Públicos de la Comunidad Autónoma de Canarias
6. Results
Value of all contracts awarded in this notice: 43 490,20 EUR
Direct award: 
Justification for direct award: The contract can be provided only by a particular economic operator because of an absence of competition for technical reasons
Other justification: Negociado sin publicidad
6.1.
Result lot identifier: LOT-0000
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: AstraZeneca Farmacéutica Spain, S.A.
Tender: 
Tender identifier: REF TEN-0001/LOT-0000
Identifier of lot or group of lots: LOT-0000
Value of the tender: 43 490,20 EUR
The tender was ranked: no
Subcontracting: No
Contract information: 
Identifier of the contract: CONT/2024/0000000241
Date on which the winner was chosen: 25/11/2024
Date of the conclusion of the contract: 23/12/2024
The contract is awarded within a framework agreement: no
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders from micro, small or medium tenderers
Number of tenders or requests to participate received: 0
Type of received submissions: Tenders
Number of tenders or requests to participate received: 1
Range of tenders: 
Value of the lowest admissible tender: 43 490,20 EUR
Value of the highest admissible tender: 43 490,20 EUR
8. Organisations
8.1.
ORG-0001
Official name: Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Registration number: 21050930148853
Registration number: Q8555011I
Town: Las Palmas de Gran Canaria
Postcode: 35019
Country: Spain
Contact point: Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Email: ucahugcdn.scs@gobiernodecanarias.org
Telephone: +034 928450147
Fax: +034 928449814
Internet address: http://www.gobiernodecanarias.org/sanidad/scs
Buyer profile: https://contrataciondelestado.es/wps/poc?uri=deeplink:perfilContratante&idBp=8GYnpPhL%2F2MQK2TEfXGy%2BA%3D%3D
Other contact points: 
Official name: Tribunal Administrativo de Contratos Públicos de la Comunidad Autónoma de Canarias
Town: Las Palmas de Gran Canaria
Postcode: 35007
Country: Spain
Email: tribunalcontratos.hacienda@gobiernodecanarias.org
Internet address: https://sede.gobcan.es/hpae/procedimientos_servicios/tramites
Roles of this organisation: 
Buyer
Review organisation
8.1.
ORG-0002
Official name: AstraZeneca Farmacéutica Spain, S.A.
Size of the economic operator: Large
Registration number: A36002129
Town: Madrid
Postcode: 28050
Country: Spain
Email: ofertasconcursos@astrazeneca.com
Telephone: +034 636619734
Roles of this organisation: 
Tenderer
Beneficial owner: 
Nationality of the owner: Spain
Winner of these lots: LOT-0000
Notice information
Notice identifier/version: d1067b62-f3ea-4a60-bc44-de58b26b558c  -  01
Form type: Result
Notice type: Contract or concession award notice – standard regime
Notice subtype: 29
Notice dispatch date: 20/01/2025 10:02:05 (UTC+01:00) Central European Time, Western European Summer Time
Languages in which this notice is officially available: Spanish
Notice publication number: 41422-2025
OJ S issue number: 14/2025
Publication date: 21/01/2025